Sign in

Michael Price

Director at OCTAVE SPECIALTY GROUP
Board

About Michael Price

Michael D. Price (age 58) has served as an independent director of Ambac Financial Group, Inc. since June 22, 2023. He is a seasoned insurance executive and actuary: former President & CEO of Platinum Underwriters Holdings, Ltd. (2005–2015), with prior leadership roles at Platinum US and The St. Paul Companies’ reinsurance segment; he is a Fellow of the Casualty Actuarial Society and a Financial Risk Manager (GARP) .

Past Roles

OrganizationRoleTenureCommittees/Impact
Platinum Underwriters Holdings, Ltd.President & CEO2005–2015Led publicly traded global P&C reinsurer
Platinum USPresident2002–2005Senior leadership in U.S. operations
The St. Paul Companies (reinsurance segment)Chief Underwriting OfficerPrior to 2005Oversaw underwriting for predecessor segment
Associated Aviation Underwriters Inc. (Global Aerospace UM)Chief Operating OfficerEarlier careerAviation insurance MGU leadership

External Roles

OrganizationRoleTenureCommittees/Notes
The Hanover Insurance Group, Inc.Director2017–2020Committee roles not disclosed in AMBC proxy

Board Governance

  • Independence: The Board determined Mr. Price is independent under NYSE rules .
  • Committee assignments:
    • Audit Committee (member; designated Audit Committee Financial Expert)
    • Compensation Committee (member)
    • Strategy Committee (member)
  • Attendance and engagement:
    • Board met 18 times in 2024; each director attended at least 97% of Board and committee meetings on which they served (applies to Mr. Price) .
    • Executive sessions of independent directors held with each regular Board meeting; no management present .
  • Leadership: Board Chair is Jeffrey S. Stein; roles of Chair and CEO are separated .

Fixed Compensation

Component2024 AmountTerms
Annual cash retainer$100,000 Paid monthly to non-employee directors
Committee chair fees$0 Chairs receive incremental fees; Mr. Price not a chair
Equity (RSUs) – grant-date fair value$199,648 Four quarterly RSU grants (~$50,000 each) with one-year vesting; settlement deferred until departure from Board
Meeting feesNot disclosedCompany reimburses reasonable out-of-pocket expenses
2024 total director comp$299,648 Cash + stock awards

RSU grant specifics (2024):

  • Grant-date fair values per quarter: $51,862 (Jan 1), $51,101 (Apr 1), $46,274 (Jul 1), $50,411 (Oct 1) .
  • Units granted per quarter: 3,147 (Jan 1), 3,299 (Apr 1), 3,699 (Jul 1), 4,497 (Oct 1) .

Performance Compensation

Directors receive time-based RSUs only; no performance-based metrics apply to non-employee director equity at Ambac. RSUs vest one year from grant date and settle upon departure from the Board; RSUs are subject to accelerated vesting under certain circumstances (e.g., change in control) .

RSU GrantGrant-Date Fair Value ($)Units GrantedVesting DateSettlement
Jan 1, 2024$51,862 3,147 Jan 1, 2025 Upon Board departure/change in control circumstances
Apr 1, 2024$51,101 3,299 Apr 1, 2025 Upon Board departure/change in control circumstances
Jul 1, 2024$46,274 3,699 Jul 1, 2025 Upon Board departure/change in control circumstances
Oct 1, 2024$50,411 4,497 Oct 1, 2025 Upon Board departure/change in control circumstances

Other Directorships & Interlocks

CompanyRelationship to AMBCPotential Interlock/Conflict Notes
The Hanover Insurance Group, Inc. (2017–2020) Unrelated insurerNo AMBC-related supplier/customer link disclosed in proxy; no interlocks identified

Expertise & Qualifications

  • Fellow, Casualty Actuarial Society; FRM (GARP) .
  • 35+ years in insurance/reinsurance underwriting, risk, and executive leadership; former CEO of a public reinsurer .
  • Designated Audit Committee Financial Expert; financially literate per SEC/NYSE standards .

Equity Ownership

MetricValue
Total beneficial ownership (as of Apr 3, 2025)115,710 shares; less than 1% of outstanding
RSUs counted toward beneficial ownership (per footnote)26,398 RSUs
Shares outstanding (record date basis)51,091,190 shares
Ownership guidelinesMust hold the lesser of $800,000 of stock or 40,000 shares within five years; directors (other than Ms. Matus) currently meet requirements (implies Price in compliance)
Hedging/pledging policyCompany maintains policies prohibiting hedging or pledging of Ambac stock
Pledged/hedged sharesNone disclosed for Mr. Price in proxy

Governance Assessment

  • Board effectiveness and independence: Strong—Mr. Price is one of six independent directors; Board runs executive sessions each meeting; separation of Chair/CEO enhances oversight .
  • Committee load and expertise: Price sits on three key committees (Audit, Compensation, Strategy), and is designated an Audit Committee Financial Expert—supports robust financial oversight .
  • Attendance/engagement: High engagement—each director attended ≥97% of Board and committee meetings; Board met 18 times in 2024, with active committee calendars (Audit 5, Compensation 11, Governance 5, Strategy 6) .
  • Director compensation alignment: Mix of cash retainer and deferred RSUs; quarterly RSUs vest in 1 year but settle at departure, promoting long-term alignment; no meeting fees; chair premia only for chairs (Price not a chair) .
  • Ownership alignment: Beneficial ownership plus RSUs and compliance with stringent director stock ownership policy—positive alignment signal; no pledging/hedging disclosed .
  • Related-party/conflicts: Ambac has a formal Related Party Transactions Policy; no related-party transactions disclosed involving Mr. Price—no conflict flags noted .
  • Compensation committee governance: Price serves on Compensation Committee; Committee is independent, met 11 times, and uses an independent consultant (Meridian)—sound process; no interlocks .
  • Shareholder sentiment: Say-on-pay support ~95% in 2024—indicates strong investor confidence in compensation governance .

Red Flags: None disclosed specific to Mr. Price (no related-party transactions, no pledging/hedging, high attendance, independent status). Continued monitoring advised given Ambac’s strategic transformation and change-in-control accelerations for executives (not directors), but no anomalies tied to Mr. Price .